BRPI0718360A2 - "composições e métodos para o tratamento do câncer com cupredoxinas e dna rico em cpg" - Google Patents
"composições e métodos para o tratamento do câncer com cupredoxinas e dna rico em cpg"Info
- Publication number
- BRPI0718360A2 BRPI0718360A2 BRPI0718360-7A2A BRPI0718360A BRPI0718360A2 BR PI0718360 A2 BRPI0718360 A2 BR PI0718360A2 BR PI0718360 A BRPI0718360 A BR PI0718360A BR PI0718360 A2 BRPI0718360 A2 BR PI0718360A2
- Authority
- BR
- Brazil
- Prior art keywords
- coupredoxins
- cpg
- compositions
- methods
- cancer treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87247106P | 2006-12-04 | 2006-12-04 | |
PCT/US2007/086393 WO2008070672A2 (en) | 2006-12-04 | 2007-12-04 | Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0718360A2 true BRPI0718360A2 (pt) | 2013-11-12 |
Family
ID=39493039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0718360-7A2A BRPI0718360A2 (pt) | 2006-12-04 | 2007-12-04 | "composições e métodos para o tratamento do câncer com cupredoxinas e dna rico em cpg" |
Country Status (12)
Country | Link |
---|---|
US (3) | US8017749B2 (pt) |
EP (1) | EP2089411A4 (pt) |
JP (2) | JP2010511408A (pt) |
KR (1) | KR20090095626A (pt) |
CN (1) | CN101600728A (pt) |
AU (1) | AU2007329375A1 (pt) |
BR (1) | BRPI0718360A2 (pt) |
CA (1) | CA2671492A1 (pt) |
MX (1) | MX2009005849A (pt) |
NO (1) | NO20092522L (pt) |
RU (1) | RU2009125599A (pt) |
WO (2) | WO2008070672A2 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US20030026782A1 (en) * | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
US6977245B2 (en) * | 1999-04-12 | 2005-12-20 | The United States Of America As Represented By The Department Of Health And Human Services | Oligodeoxynucleotide and its use to induce an immune response |
WO2000061151A2 (en) | 1999-04-12 | 2000-10-19 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Oligodeoxynucleotide and its use to induce an immune response |
US20030129251A1 (en) * | 2000-03-10 | 2003-07-10 | Gary Van Nest | Biodegradable immunomodulatory formulations and methods for use thereof |
US9096663B2 (en) * | 2001-02-15 | 2015-08-04 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof |
US7381701B2 (en) * | 2001-02-15 | 2008-06-03 | The Borad Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
US7691383B2 (en) * | 2004-10-07 | 2010-04-06 | The Board Of Trustees Of The University Of Illinois | Cupredoxin derived transport agents and methods of use thereof |
PT1404873E (pt) * | 2001-06-21 | 2013-07-30 | Dynavax Tech Corp | Compostos de imunomodulação quiméricos e métodos de utilização dos mesmos |
JP2006515277A (ja) * | 2002-10-29 | 2006-05-25 | コーリー ファーマシューティカル グループ, リミテッド | C型肝炎ウィルス感染の処置および予防に関する方法および製品 |
US7615539B2 (en) * | 2003-09-25 | 2009-11-10 | Coley Pharmaceutical Group, Inc. | Nucleic acid-lipophilic conjugates |
US9598470B2 (en) * | 2004-10-07 | 2017-03-21 | Craig W. Beattie | Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways |
MX2009005849A (es) * | 2006-12-04 | 2009-08-12 | Univ Illinois | Composiciones y metodos para tratar cancer con adn rico en cpg y cupredoxinas. |
JP2010518123A (ja) * | 2007-02-08 | 2010-05-27 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ | 癌をキュプレドキシンで予防するための組成物および方法 |
PE20110998A1 (es) | 2008-12-09 | 2012-02-10 | Coley Pharm Group Inc | Oligonucleotidos inmunoestimuladores |
US8552165B2 (en) * | 2008-12-09 | 2013-10-08 | Heather Davis | Immunostimulatory oligonucleotides |
WO2014049604A2 (en) * | 2012-09-05 | 2014-04-03 | Amrita Therapeutics Limited | A novel biomedical device for cancer therapy |
CN104869984A (zh) * | 2012-12-21 | 2015-08-26 | 泰华制药工业有限公司 | 醋酸格拉默的口腔透黏膜给药 |
EP3115039B1 (de) * | 2015-07-09 | 2021-12-15 | beniag GmbH | Verfahren zum herstellen einer fusionsmischung zur übertragung eines geladenen moleküls in und/oder durch eine lipidmembran |
RU204475U1 (ru) * | 2020-09-24 | 2021-05-26 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт медицины труда имени академика Н.Ф. Измерова" (ФГБНУ "НИИ МТ") | Медицинский аппликатор для местного лечения кожных заболеваний |
Family Cites Families (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6167490A (ja) * | 1984-09-07 | 1986-04-07 | Sagami Chem Res Center | P▲l▼プロモ−タ−を有する環状二重鎖dna |
US4817384A (en) | 1986-08-13 | 1989-04-04 | Toyota Jidosha Kabushiki Kaisha | Double air-fuel ratio sensor system having improved exhaust emission characteristics |
US5567411A (en) | 1986-11-10 | 1996-10-22 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group |
US5252317A (en) | 1986-11-10 | 1993-10-12 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Amplifier molecules for diagnosis and therapy derived from 3,5-bis[1-(3-amino-2,2-bis (aminomethyl)-propyl) oxymethyl] benzoic acid |
GB8923843D0 (en) | 1989-10-23 | 1989-12-13 | Salutar Inc | Compounds |
US5679810A (en) | 1990-01-19 | 1997-10-21 | Salutar, Inc. | Linear oligomeric polychelant compounds |
DE4138042C2 (de) | 1991-11-19 | 1993-10-14 | Biotechnolog Forschung Gmbh | Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel |
US5760191A (en) | 1993-02-05 | 1998-06-02 | Nycomed Imaging As | Macrocyclic complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods |
US5417959A (en) | 1993-10-04 | 1995-05-23 | Mallinckrodt Medical, Inc. | Functionalized aza-crytand ligands for diagnostic imaging applications |
US5520904A (en) | 1995-01-27 | 1996-05-28 | Mallinckrodt Medical, Inc. | Calcium/oxyanion-containing particles with a polymerical alkoxy coating for use in medical diagnostic imaging |
EP0727225A3 (en) | 1995-02-14 | 1997-01-15 | Sonus Pharma Inc | Compositions and methods for directed ultrasonic imaging |
US5801228A (en) | 1995-06-07 | 1998-09-01 | Nycomed Imaging As | Polymeric contrast agents for medical imaging |
ATE218556T1 (de) | 1995-11-17 | 2002-06-15 | Biotechnolog Forschung Gmbh | Epothilon-derivate und deren herstellung |
US6011029A (en) | 1996-02-26 | 2000-01-04 | Bristol-Myers Squibb Company | Inhibitors of farnesyl protein transferase |
US5804161A (en) | 1996-05-14 | 1998-09-08 | Nycomed Salutar Inc. | Contrast agents |
AU3585397A (en) | 1996-06-27 | 1998-01-14 | G.D. Searle & Co. | Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
DK1367057T3 (da) | 1996-11-18 | 2009-01-19 | Biotechnolog Forschung Gmbh | Epothiloner E og F |
CA2273083C (en) | 1996-12-03 | 2012-09-18 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
US6380394B1 (en) | 1996-12-13 | 2002-04-30 | The Scripps Research Institute | Epothilone analogs |
US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
US7807182B2 (en) | 1996-12-31 | 2010-10-05 | Colorado State University Research Foundation | Early detection of mycobacterial disease using peptides |
KR100494179B1 (ko) | 1997-02-25 | 2005-06-10 | 게젤샤프트 퓌어 비오테크놀로기쉐 포르슝 엠베하(게베에프) | 변환된 측쇄를 가진 에포틸론 |
GB9801231D0 (en) | 1997-06-05 | 1998-03-18 | Merck & Co Inc | A method of treating cancer |
WO1999002224A1 (en) | 1997-07-07 | 1999-01-21 | Lewis Robert D | Statistical analysis and feedback system for sports employing a projectile |
US6605599B1 (en) | 1997-07-08 | 2003-08-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
US6384230B1 (en) | 1997-07-16 | 2002-05-07 | Schering Aktiengesellschaft | Thiazole derivatives, method for their production and use |
FR2766185B1 (fr) | 1997-07-18 | 2001-06-15 | Rhone Poulenc Rorer Sa | Medicaments contenant en tant que principe actif au moins un derive substitue de polyhydroxylalkylpyrazines, les nouveaux derives polyhydroxylalkylpyrazines et leur preparation |
DK1005465T3 (da) | 1997-08-09 | 2007-11-05 | Bayer Schering Pharma Ag | Nye epothilon-derivater, fremgangsmåde til fremstilling heraf og deres farmaceutiske anvendelse |
IT1297288B1 (it) | 1997-10-31 | 1999-09-01 | Denis Robert Gemmani | Struttura di grigliato metallico dentellato particolarmente per il completamento di manufatti ed opere edili ad uso civile od industriale |
US6040321A (en) | 1997-11-12 | 2000-03-21 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
US6365749B1 (en) | 1997-12-04 | 2002-04-02 | Bristol-Myers Squibb Company | Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
US6551795B1 (en) * | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
MXPA00008365A (es) | 1998-02-25 | 2002-11-07 | Sloan Kettering Inst Cancer | Sintesis de epotilonas, intermediarios y analogos de las mismas. |
US6498257B1 (en) | 1998-04-21 | 2002-12-24 | Bristol-Myers Squibb Company | 2,3-olefinic epothilone derivatives |
US6399638B1 (en) | 1998-04-21 | 2002-06-04 | Bristol-Myers Squibb Company | 12,13-modified epothilone derivatives |
DE19826988A1 (de) | 1998-06-18 | 1999-12-23 | Biotechnolog Forschung Gmbh | Epothilon-Nebenkomponenten |
WO1999067253A2 (en) | 1998-06-22 | 1999-12-29 | Novartis Ag | Desmethyl epothilones |
AU5036999A (en) | 1998-06-30 | 2000-01-17 | Schering Aktiengesellschaft | Epothilon derivatives, their preparation process, intermediate products and their pharmaceutical use |
EP1985702A3 (en) * | 2000-12-08 | 2010-08-18 | Coley Pharmaceutical GmbH | CPG-like nucleic acids and methods of use thereof |
US7301010B2 (en) * | 2001-02-15 | 2007-11-27 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating HIV infection with cupredoxin and cytochrome c |
US7381701B2 (en) * | 2001-02-15 | 2008-06-03 | The Borad Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
US7491394B2 (en) * | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
US7338766B2 (en) * | 2001-02-15 | 2008-03-04 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating malaria with cupredoxin and cytochrome |
US9096663B2 (en) * | 2001-02-15 | 2015-08-04 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof |
AU2002311753B2 (en) | 2001-02-15 | 2008-04-03 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
US7618939B2 (en) * | 2001-02-15 | 2009-11-17 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to prevent cancer with cupredoxins |
US7556810B2 (en) | 2005-07-19 | 2009-07-07 | The Board Of Trustees Of The University Of Ilinois | Compositions and methods to control angiogenesis with cupredoxins |
US7691383B2 (en) * | 2004-10-07 | 2010-04-06 | The Board Of Trustees Of The University Of Illinois | Cupredoxin derived transport agents and methods of use thereof |
US7338776B2 (en) | 2002-03-20 | 2008-03-04 | Jcr Pharmaceuticals Co., Ltd. | Production of UGPPase |
KR100456681B1 (ko) * | 2002-05-22 | 2004-11-10 | 주식회사 대웅 | 박테리아의 염색체 dna 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물 |
CN1506375A (zh) * | 2002-12-12 | 2004-06-23 | 浙江养生堂天然药物研究所有限公司 | 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物 |
CN100486987C (zh) | 2003-03-05 | 2009-05-13 | 长春华普生物技术有限公司 | 抗病毒和抗肿瘤的含CpG单链脱氧寡核苷酸 |
US9434770B2 (en) * | 2004-10-07 | 2016-09-06 | Tapas K Das Gupta | Modified cupredoxin derived peptides |
US9968685B2 (en) * | 2004-10-07 | 2018-05-15 | Brad N. Taylor | Methods to treat cancer with cupredoxins |
US8158574B2 (en) * | 2004-10-07 | 2012-04-17 | Cdg Therapeutics, Inc. | Compositions and methods to prevent cancer with cupredoxins |
US9598470B2 (en) * | 2004-10-07 | 2017-03-21 | Craig W. Beattie | Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways |
US20090208476A1 (en) * | 2006-05-19 | 2009-08-20 | Tapas Das Gupta | Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |
US10675326B2 (en) * | 2004-10-07 | 2020-06-09 | The Board Of Trustees Of The University Of Illinois | Compositions comprising cupredoxins for treating cancer |
JP2008545398A (ja) * | 2005-05-20 | 2008-12-18 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ | キュプレドキシンおよびシトクロムcを用いてhiv感染を治療するための組成物および方法 |
MX2008000994A (es) * | 2005-07-19 | 2008-03-19 | Univ Illinois | Agentes de transporte para cruzar la barrera hematoencefalica y hacia el interior de las celulas de cancer cerebral, y metodos para el uso de los mismos. |
JP2009502797A (ja) * | 2005-07-19 | 2009-01-29 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ | 血管形成をキュプレドキシンで制御するための組成物および方法 |
JP4582004B2 (ja) * | 2006-01-13 | 2010-11-17 | セイコーエプソン株式会社 | 発光装置および電子機器 |
US10266868B2 (en) * | 2006-05-19 | 2019-04-23 | The Board Of Trustees Of The University Of Illinois | Compositions for treating HIV infection with cupredoxin and cytochrome C |
US20140287990A1 (en) * | 2006-05-19 | 2014-09-25 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to concurrently treat and/or prevent multiple diseases with cupredoxins |
KR100801002B1 (ko) * | 2006-06-05 | 2008-02-11 | 삼성전자주식회사 | 무선 네트워크 상에서 멀티미디어 데이터를 전송/재생하는방법, 및 그 방법을 이용한 무선 기기 |
WO2008033820A2 (en) * | 2006-09-11 | 2008-03-20 | The Board Of Trustees Of The University Of Illinois | Modifications of cupredoxin derived peptides and methods of use thereof |
BRPI0714987A2 (pt) * | 2006-09-14 | 2013-07-30 | Trutees Of The University Of Illinoi Board Of | composiÇÕes e mÉtodos para a prevenÇço do cÂncer com cupredoxina |
US8685720B2 (en) * | 2006-11-03 | 2014-04-01 | The Trustees Of Princeton University | Engineered cellular pathways for programmed autoregulation of differentiation |
MX2009005849A (es) * | 2006-12-04 | 2009-08-12 | Univ Illinois | Composiciones y metodos para tratar cancer con adn rico en cpg y cupredoxinas. |
JP2010518123A (ja) * | 2007-02-08 | 2010-05-27 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ | 癌をキュプレドキシンで予防するための組成物および方法 |
WO2009078977A2 (en) * | 2007-12-14 | 2009-06-25 | Cdg Therapeutics Inc | Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |
JP5873499B2 (ja) * | 2010-10-01 | 2016-03-01 | アムリタ セラピューティクス リミテッドAmrita Therapeutics Limited | 抗がん剤 |
AU2012232965B2 (en) * | 2011-09-30 | 2015-07-09 | Elaflex Hiby Tanktechnik Gmbh & Co. | Dispensing Valve |
WO2017012661A1 (en) * | 2015-07-22 | 2017-01-26 | Curetis Gmbh | Genetic testing for predicting resistance of pseudomonas species against antimicrobial agents |
KR102024186B1 (ko) * | 2017-05-04 | 2019-09-23 | 주식회사 젠센 | 톨-유사 수용체(tlr) 억제를 위한 펩타이드 및 이를 포함하는 약학적 조성물 |
-
2007
- 2007-12-04 MX MX2009005849A patent/MX2009005849A/es active IP Right Grant
- 2007-12-04 RU RU2009125599/10A patent/RU2009125599A/ru not_active Application Discontinuation
- 2007-12-04 WO PCT/US2007/086393 patent/WO2008070672A2/en active Search and Examination
- 2007-12-04 EP EP07868980A patent/EP2089411A4/en not_active Withdrawn
- 2007-12-04 CN CNA2007800505771A patent/CN101600728A/zh active Pending
- 2007-12-04 US US11/950,165 patent/US8017749B2/en active Active
- 2007-12-04 AU AU2007329375A patent/AU2007329375A1/en not_active Abandoned
- 2007-12-04 BR BRPI0718360-7A2A patent/BRPI0718360A2/pt not_active Application Discontinuation
- 2007-12-04 CA CA002671492A patent/CA2671492A1/en not_active Abandoned
- 2007-12-04 KR KR1020097013765A patent/KR20090095626A/ko not_active Application Discontinuation
- 2007-12-04 JP JP2009540425A patent/JP2010511408A/ja active Pending
- 2007-12-04 WO PCT/US2007/086385 patent/WO2008070666A2/en active Application Filing
-
2009
- 2009-07-03 NO NO20092522A patent/NO20092522L/no not_active Application Discontinuation
-
2011
- 2011-09-12 US US13/230,055 patent/US9969781B2/en active Active
-
2014
- 2014-04-10 JP JP2014081387A patent/JP2014158486A/ja active Pending
-
2017
- 2017-12-11 US US15/837,066 patent/US11046733B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2010511408A (ja) | 2010-04-15 |
KR20090095626A (ko) | 2009-09-09 |
US20200172581A1 (en) | 2020-06-04 |
US11046733B2 (en) | 2021-06-29 |
AU2007329375A1 (en) | 2008-06-12 |
EP2089411A2 (en) | 2009-08-19 |
US20120014877A1 (en) | 2012-01-19 |
US20090226405A1 (en) | 2009-09-10 |
US8017749B2 (en) | 2011-09-13 |
WO2008070666A2 (en) | 2008-06-12 |
CA2671492A1 (en) | 2008-06-12 |
JP2014158486A (ja) | 2014-09-04 |
US9969781B2 (en) | 2018-05-15 |
WO2008070672A2 (en) | 2008-06-12 |
CN101600728A (zh) | 2009-12-09 |
NO20092522L (no) | 2009-09-04 |
EP2089411A4 (en) | 2010-01-27 |
MX2009005849A (es) | 2009-08-12 |
RU2009125599A (ru) | 2011-01-20 |
WO2008070672A3 (en) | 2009-04-16 |
AU2007329375A2 (en) | 2009-08-13 |
WO2008070666A3 (en) | 2009-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0718360A2 (pt) | "composições e métodos para o tratamento do câncer com cupredoxinas e dna rico em cpg" | |
BRPI0818963A2 (pt) | Conjugado anticorpo-molécula parceira e método para tratar câncer em um indivíduo | |
BRPI0716354A2 (pt) | "composiÇço e mÉtodo" | |
BRPI0906099A2 (pt) | "método de tratamento do câncer em um indivíduo" | |
IL188487A0 (en) | Topical skin treating compositions | |
BRPI0819361A2 (pt) | Composição de tratamento de cabelos e agente de tratamento | |
BRPI0716300A2 (pt) | Artigo e mistura | |
HK1136822A1 (en) | Therapeutic compounds and their use in cancer | |
PL2578081T4 (pl) | Kompozycje, sposoby i urządzenia do leczenia chorób wątroby | |
HK1201182A1 (en) | Pegylated il-10 for use in treating cancer or tumor il-10 | |
EP1959929A4 (en) | COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING | |
IL186963A0 (en) | Methods and compositions for treating pain | |
EP1890712A4 (en) | COMPOSITIONS AND METHODS FOR TREATING PAIN | |
GB0612301D0 (en) | DNA molecules and methods | |
BRPI0822349A2 (pt) | composições e métodos para tratar doenças lisossômicas | |
BRPI0812932A2 (pt) | Composições e métodos de tratar câncer | |
EP2012798A4 (en) | USE OF INOSITOL-TRIPYROPHOSPHATE IN THE TREATMENT OF TUMORS AND DISEASES | |
BRPI0716754A2 (pt) | composiÇço À base de xantoxilina e a respectiva utilizaÇço em cosmÉtica | |
BRPI0810207A2 (pt) | Métodos e composições para o tratamento de câncer | |
SI2061458T1 (sl) | Sestavki topiramata in metode za njihovo uporabo | |
PL2012805T3 (pl) | Kompozycja lecznicza i jej zastosowanie | |
GB0718918D0 (en) | Compositions and methods for treating skin conditions | |
EP1998735A4 (en) | ACYL LACTYLATE COMPOSITIONS FOR RINSE AND NON-RINSE APPLICATIONS FOR SKIN AND HAIR | |
HK1129596A1 (en) | Methods and compositions for treating disease | |
GB0619816D0 (en) | Novel interferon-alpha constructs for use in the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |